Wydawca
|
|
ukazuje się od 1994 roku |
| Wydawca
|
|
ukazuje się od 1994 roku |
» Ocena przydatności interferonowego testu QuantiFERON-TB Gold in Tube i tuberkulinowego testu skórnego w immunodiagnostyce zakażeń Mycobacterium tuberculosis© Borgis - Nowa Medycyna 1, s. 32-36
*Jolanta Paluch-Oleś, Maria Kozioł-Montewka
Ocena przydatności interferonowego testu QuantiFERON-TB Gold in Tube i tuberkulinowego testu skórnego w immunodiagnostyce zakażeń Mycobacterium tuberculosis
Evaluation of usefulness of QuantiFERON-TB Gold in Tube assay and Tuberculin Skin Test for immunodiagnosis of Mycobacterium tuberculosis infection
Katedra i Zakład Mikrobiologii Lekarskiej Uniwersytetu Medycznego w Lublinie
Kierownik Katedry i Zakładu: prof. dr hab. Maria Kozioł-Montewka Summary
Key words:
Piśmiennictwo
1. World Health Oragnization. Global Tuberculosis Control: Surveillance, Planning, Finacing. WHO Report 2005, Geneva, Switzerland (2005). 2. Rothel James S, Andersen Peter (2006): Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? Expert Review of Anti-infective Therapy 2006; 3, 6: 981-993. 3. Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection. American Thoracic Society. Am. J. Resir. Crit. Care Med. 2000; 161: 221-247. 4. Majewska-Zalewska Hanna: Technika wykonania próby tuberkulinowej i szczepienia BCG. Medycyna Praktyczna, Pediatria, 1999. 5. Zio-kowski Jerzy: Diagnostyka gručlicy pierwotnej. Klinika Pediatryczna 2007; Vol 15/2: 257-264. 6. Tissot F et al.: Influence of bacille Calmette-Guerin vaccination on size of tuberculin skin test reaction: to what size? Clin Infect Dis 2005; 40: 211-217. 7. Barnes PF: Diagnosing latent tuberculosis infection: the 100-year upgrade. Am J Respir Crit Care Med 2001; 163: 807-808.8. Ajit Lalvani. (2004) Editorial Commentary: Counting Antigen-Specific T Cells: A New Approach for Monitoring Response to Tuberculosis Treatment? Clinical Infectious Diseases 2004; 38, 5: 757-759. 9. Mazurek GH et al.: Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep; 54:49-55, 2005. 10. Mazurek GH, LoBue PA, Daley CL, et al. Comparison of a whole-blood interferon - assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection JAMA 2001; 286: 1740-1747. 11. Mori T et al.: Specific detection of tuberculosis infection: an interferongamma-based assay using new antigens. Am J Respir Crit Care Med. 2004; 170: 59-64. 12. Kang YA et al.: Discrepancy between the tuberculin skin test and the whole-blood interferon g assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005; 293: 2756-61. 13. Ferrara G et al.: Routine hospital use of a commercial whole blood interferon-g assay for tuberculosis infection. Am J Respir Crit Care Med 2005; 172: 631-5. 14. Brock I et al.: Latent Tuberculosis in HIV positive, diagnosed by the M. tuberculosis Specific Interferon Gamma test. Respir Res. 2006; 7: 56. 15. Selwyn PA et al.: Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med. 1992; 327: 1697-1703. 16. Ormerod LP et al.: BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Thorax. 2005; 60: 800-805. 17. Ponce de León D et al.: Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis. Ann Rheum Dis. 2005; 64: 1360-1361. 18. Winthrop KL et al.: Tuberculosis associated with therapy against tumor necrosis factor alpha. Arthritis Rheum. 2005; 52: 2968-2974. 19. Libshitz HI et al.: Tuberculosis in cancer patients: an update. J Thorac Imaging. 1997; 12: 41-46. 20. Fietta A et al.: A comparison of a whole-blood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection. Amer J Infect Cont. 2003; 31: 347-353. 21. Nakaoka H et al.: Risk for tuberculosis among children. Emerg Infect Dis 2006; 12: 1383-8. 22. Dogra S et al.: Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J Infec 2007; 54: 267-76. 23. Detjen AK et al.: Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007; 45: 322-8. 24. Okada K et al.: Performance of an interferongamma release assay for diagnosing latent tuberculosis infection in children. Epidemiol Infect 2007; 8: 1-9. 25. Mori M et al.: Usefulness of interferon-gamma based diagnosis of Mycobacterium tuberculosis infection in childhood tuberculosis. Kansenshogaku Zasshi 2005; 79: 937-44.
otrzymano/received: 2009-02-25 zaakceptowano/accepted: 2009-03-27 Adres/address: *Jolanta Paluch-Oleś Katedra i Zakład Mikrobiologii Lekarskiej UM ul. Chodźki 1, 20-093 Lublin tel.: (0-81) 742-37-48 e-mail: ojo46@wp.pl Pełna wersja artykułu Ocena przydatności interferonowego testu QuantiFERON-TB Gold in Tube i tuberkulinowego testu skórnego w immunodiagnostyce zakażeń Mycobacterium tuberculosis dostępna w Czytelni Medycznej Borgis. |
english version
